Item 2.02 Results of Operations and Financial Condition.

On October 21, 2021, Plus Therapeutics, Inc. (the "Company") reported financial results for the quarter ended September 30, 2021 and other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated by reference.

The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, whether made before or after today's date, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such filing.



Item 9.01         Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number                                        Description
    99.1            Press Release Announcing Financial Results, dated October 21,
                  2021  .
    104           Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses